Q1 EPS Estimates for Henry Schein Reduced by Leerink Partnrs

Henry Schein, Inc. (NASDAQ:HSIC) – Analysts at Leerink Partnrs reduced their Q1 2025 EPS estimates for Henry Schein in a research report issued to clients and investors on Wednesday, April 9th. Leerink Partnrs analyst M. Cherny now anticipates that the company will post earnings per share of $1.12 for the quarter, down from their prior forecast of $1.14. The consensus estimate for Henry Schein’s current full-year earnings is $4.74 per share. Leerink Partnrs also issued estimates for Henry Schein’s Q2 2025 earnings at $1.14 EPS, Q4 2025 earnings at $1.16 EPS, FY2025 earnings at $4.61 EPS and FY2028 earnings at $6.00 EPS.

Several other analysts also recently weighed in on HSIC. Barrington Research reiterated an “outperform” rating and issued a $90.00 price objective on shares of Henry Schein in a research report on Wednesday, February 26th. Jefferies Financial Group increased their price target on shares of Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research report on Thursday, January 23rd. UBS Group decreased their price objective on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 26th. Bank of America upgraded shares of Henry Schein from an “underperform” rating to a “buy” rating and increased their target price for the stock from $69.00 to $84.00 in a report on Monday, January 6th. Finally, StockNews.com upgraded Henry Schein from a “hold” rating to a “buy” rating in a report on Wednesday. Five analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Henry Schein currently has an average rating of “Moderate Buy” and an average price target of $81.10.

Henry Schein Trading Up 1.4 %

Shares of HSIC stock opened at $64.46 on Friday. The business has a 50-day moving average of $71.90 and a 200 day moving average of $72.23. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. Henry Schein has a 1-year low of $60.56 and a 1-year high of $82.49. The stock has a market capitalization of $8.00 billion, a PE ratio of 26.53, a P/E/G ratio of 2.13 and a beta of 0.84.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). The business had revenue of $3.19 billion during the quarter, compared to analysts’ expectations of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. Henry Schein’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same period last year, the company posted $0.66 EPS.

Hedge Funds Weigh In On Henry Schein

Several large investors have recently made changes to their positions in the business. Versant Capital Management Inc raised its position in shares of Henry Schein by 274.6% in the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $32,000 after purchasing an additional 335 shares during the last quarter. Investment Management Corp VA ADV bought a new stake in Henry Schein during the 4th quarter valued at about $32,000. Venturi Wealth Management LLC raised its holdings in Henry Schein by 3,347.1% in the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company’s stock worth $41,000 after buying an additional 569 shares during the last quarter. Quent Capital LLC lifted its stake in shares of Henry Schein by 91.2% in the fourth quarter. Quent Capital LLC now owns 677 shares of the company’s stock worth $47,000 after buying an additional 323 shares in the last quarter. Finally, Smartleaf Asset Management LLC grew its holdings in shares of Henry Schein by 23.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company’s stock valued at $52,000 after buying an additional 143 shares during the last quarter. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Henry Schein

In related news, Director Philip A. Laskawy sold 2,604 shares of the stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total value of $184,988.16. Following the completion of the transaction, the director now directly owns 24,805 shares in the company, valued at $1,762,147.20. This trade represents a 9.50 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Bradford C. Connett sold 4,036 shares of the business’s stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total transaction of $287,161.40. Following the sale, the chief executive officer now directly owns 62,688 shares in the company, valued at $4,460,251.20. The trade was a 6.05 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.14% of the company’s stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.